Clinical Trials

12 enrolled

Brain Neoplasms, Glioblastoma, Recurrence

NCT07263438 2026-02-13

Phenix

Phase 2 Recruiting

59 enrolled

Phase 2 Active not recruiting

Glioblastoma, Recurrence

NCT05797246 2026-01-26

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

21 enrolled

DNA Virus Infections, Infections, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Pathologic Processes, Recurrence, Respiratory Tract Diseases, Respiratory Tract Infections, Tumor Virus Infections, Virus Diseases, Neoplasms, Squamous Cell, Disease Attributes, Papillomavirus Infections

NCT07340164 2026-01-14

TROY

Phase 2 Not yet recruiting

116 enrolled

Phase 1 Active not recruiting

Ovarian Neoplasms, Recurrence

NCT01552434 2025-10-14

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

155 enrolled

BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

NCT06859775 2025-06-06

SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer

Phase 1/2 Recruiting

100 enrolled

Uterine Cervical Neoplasms, Recurrence

NCT04868708 2025-03-04

A Study of AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer

50 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Uterine Cervical Neoplasms, Recurrence

NCT06801730 2025-01-30

NALIRIBVRG

Phase 2 Recruiting

38 enrolled

Phase 2 Not yet recruiting

Glioma, Recurrence

NCT04739670 2024-03-01

BELLA

Phase 2 Unknown

31 enrolled

Breast

Recurrence, Triple Negative Breast Neoplasms

NCT06041490 2023-09-18

Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation

88 enrolled

GastrointestinalSarcoma

Carcinoma, Hepatocellular, Recurrence, Osteosarcoma

NCT05718466 2023-07-17

Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy

Phase 3 Completed

35 enrolled 13 charts

Phase 3 Not yet recruiting

Glioblastoma, Recurrence

NCT05798819 2023-04-05

A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

424 enrolled

Recurrence

NCT02761070 2023-03-08

RE-GEND

Phase 3 Unknown

146 enrolled

Phase 3 Not yet recruiting

Glioblastoma, Recurrence, Disease Progression

NCT03713944 2023-03-01

Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer

Phase 2 Terminated

30 enrolled 28 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT05715840 2023-02-08

Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)

368 enrolled

Recurrence

NCT04015739 2022-08-17

BOLD

Phase 2 Unknown

74 enrolled

Carcinoma, Ovarian Epithelial, Recurrence

NCT02337491 2020-12-22

Pembrolizumab +/- Bevacizumab for Recurrent GBM

80 enrolled 13 charts

Glioblastoma, Recurrence

NCT01967810 2020-02-25

ANG1005 in Patients With Recurrent High-Grade Glioma

73 enrolled

Brain Neoplasms, Glioblastoma, Glioma, Recurrence

NCT01498328 2020-02-17

ReACT

127 enrolled

CNSSarcoma

Brain Neoplasms, Glioblastoma, Neoplasms, Recurrence, Gliosarcoma

NCT02414165 2020-02-07

Toca5

Phase 2/3 Terminated

403 enrolled

Astrocytoma, Glioblastoma, Recurrence

NCT00846612 2019-09-30

Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer

15 enrolled

Ovarian Neoplasms, Recurrence

NCT01782976 2018-01-19

Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

Phase 2 Withdrawn

Glioblastoma, Recurrence

NCT01031381 2016-08-30

RADBEV

50 enrolled 7 charts

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms, Recurrence

NCT02060955 2016-06-06

Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan

Phase 2 Terminated

25 enrolled

Glioblastoma, Recurrence

NCT01113398 2015-12-10

AMG 102 and Avastin for Recurrent Malignant Glioma

36 enrolled 9 charts

CNSSarcoma

Glioblastoma, Glioma, Recurrence, Gliosarcoma

NCT00756340 2015-10-14

A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors

16 enrolled

Recurrence, Central Nervous System Neoplasms

NCT00271609 2014-04-29

Bevacizumab for Recurrent Malignant Glioma

88 enrolled 11 charts

Brain Neoplasms, Glioma, Recurrence

NCT01017250 2014-02-28

Radiosurgery and Avastin for Recurrent Malignant Gliomas

Phase NA Completed

15 enrolled 23 charts

Glioma, Recurrence

NCT00458731 2014-02-19

Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma

LymphoidOther hematologic neoplasmSarcoma

57 enrolled

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Recurrence, Sezary Syndrome, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating, Intraocular Lymphoma

NCT00356122 2011-10-17

Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)

53 enrolled 14 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Recurrence

NCT00463203 2011-06-29

Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy

54 enrolled

Brain Neoplasms, Ependymoma, Glioma, Recurrence

NCT00095225 2008-01-29

A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)